Age-Related Macular Degeneration (AMD - Dry & Wet)
Degenerative breakdown of the central macular retina in older adults, categorized into atrophic (Dry AMD) and exudative neovascular (Wet AMD).
Article Table of Contents
1. Comprehensive Overview
Age-Related Macular Degeneration (AMD) is a progressive neurodegenerative disease of the central retinal photoreceptor-RPE-Bruch's membrane complex, serving as the leading cause of irreversible legal blindness in individuals over age 60.
Clinical Forms: 1. Dry (Non-Neovascular / Atrophic) AMD (85–90%): Characterized by metabolic dysfunction of RPE cells, leading to extracellular lipid-protein deposits called Drusen beneath the RPE. Progresses slowly to geographic atrophy (GA) with confluent loss of RPE and overlying photoreceptors. 2. Wet (Neovascular / Exudative) AMD (10–15%): Responsible for the majority of acute, severe visual loss. Driven by hypoxia and VEGF overexpression, pathological choroidal neovascular membranes (CNVM) proliferate through Bruch's membrane into sub-RPE or subretinal spaces. Vascular leakage, hemorrhage, and subsequent disciform fibrotic scarring result in devastating central scotomas.
Modern Therapeutic Landscape: Intravitreal Anti-VEGF regimens (Faricimab, Aflibercept, Ranibizumab) have converted Wet AMD from an untreatable blinding disease into a manageable chronic condition. Oral AREDS-2 micronutrient supplements slow Dry AMD progression to advanced stages.
2. Symptoms & Warning Signs
If you observe any of the following symptoms repeatedly, an eye exam is strongly recommended:
- Gradual (dry) or rapid (wet) loss of central visual acuity, while peripheral vision remains completely preserved
- Metamorphopsia: Linear geometric lines appear distorted, bent, or broken (tested on the Amsler grid)
- Dense central scotoma (a gray, dark, or blank blind spot directly in the line of sight)
- Increased requirement for bright reading illumination and magnification tools
- Delayed dark adaptation recovery when moving from bright sunlight into dimmed rooms
- Color desaturation and impaired contrast sensitivity
3. Causes & Risk Factors
- 1Aging: The primary non-modifiable risk factor, rising exponentially past age 65
- 2Cigarette smoking: The major modifiable risk factor, multiplying AMD risk by 3–4x and accelerating neovascular conversion
- 3Genetic polymorphism in alternative complement pathways (CFH, C3, ARMS2/HTRA1)
- 4Cardiovascular risk factors (hypertension, elevated body mass index, hypercholesterolemia)
- 5Lifetime cumulative blue light and ultraviolet solar radiation exposure
4. Treatments & Medical Management
5. Prevention & Daily Eye Care Advice
- Strict, permanent cessation of cigarette smoking
- Mediterranean diet rich in dark leafy green vegetables (spinach, kale) and omega-3 fatty acid fatty fish (salmon, tuna)
- Wearing UV-blocking and blue-light filtering sunglasses outdoors
- Regular annual dilated fundus exams and Spectral-Domain OCT imaging past age 60
6. When to Seek Emergency Eye Care
Visit an immediate eye emergency center if you experience any of the following critical indicators:
- ⚠Sudden onset of straight line distortion or waviness on an Amsler grid test (hallmark of new wet CNVM)
- ⚠Appearance of a new dark or missing spot directly in central fixation
- ⚠Rapid, acute drop in central reading vision
7. Frequently Asked Questions
Q:Does Macular Degeneration (AMD) cause total black blindness?
No. AMD specifically targets the central macula while leaving peripheral vision completely intact. Patients retain peripheral navigational sight, mobility, and independent living capabilities without total darkness.